Steven B Bernitz's Net Worth
$6.1 Million
Who is Steven B Bernitz?
Steven B Bernitz has an estimated net worth of $6.1 Million. This is based on reported shares across multiple companies, which include SYNTA PHARMACEUTICALS CORP, and Coley Pharmaceutical Group, Inc..
SEC CIK
Steven B Bernitz's CIK is 0001335334
Past Insider Trading and Trends
2013 was Steven B Bernitz's most active year for acquiring shares with 2 total transactions. Steven B Bernitz's most active month to acquire stocks was the month of November. 2013 saw Steven B Bernitz paying a total of $2.50 for 175,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $243.89
SVP, Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 25K |
—
| $2.50 | 25K |
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coley Pharmaceutical Group, Inc. No price found
SVP, Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||